Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter
- PMID: 9661885
Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter
Abstract
Multidrug resistance-associated protein (MRP) and canalicular multispecific organic anion transporter (cMOAT) are closely related mammalian ATP-binding cassette transporters that export organic anions from cells. Transfection studies have established that MRP confers resistance to natural product cytotoxic agents, and recent evidence suggests the possibility that cMOAT may contribute to cytotoxic drug resistance as well. Based upon the potential importance of these transporters in clinical drug resistance and their important physiological roles in the export of the amphiphilic products of phase I and phase II metabolism, we sought to identify other MRP-related transporters. Using a degenerate PCR approach, we isolated a cDNA that encodes a novel ATP-binding cassette transporter, which we designated MOAT-B. The MOAT-B gene was mapped using fluorescence in situ hybridization to chromosome band 13q32. Comparison of the MOAT-B predicted protein with other transporters revealed that it is most closely related to MRP, cMOAT, and the yeast organic anion transporter YCF1. Although MOAT-B is closely related to these transporters, it is distinguished by the absence of a approximately 200 amino acid NH2-terminal hydrophobic extension that is present in MRP and cMOAT and which is predicted to encode several transmembrane spanning segments. In addition, the MOAT-B tissue distribution is distinct from MRP and cMOAT. In contrast to MRP, which is widely expressed in tissues, including liver, and cMOAT, the expression of which is largely restricted to liver, the MOAT-B transcript is widely expressed, with particularly high levels in prostate, but is barely detectable in liver. These data indicate that MOAT-B is a ubiquitously expressed transporter that is closely related to MRP and cMOAT and raise the possibility that it may be an organic anion pump relevant to cellular detoxification.
Similar articles
-
MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver.Br J Cancer. 1999 Jul;80(9):1342-9. doi: 10.1038/sj.bjc.6690527. Br J Cancer. 1999. PMID: 10424734 Free PMC article.
-
Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins.J Natl Cancer Inst. 1998 Nov 18;90(22):1735-41. doi: 10.1093/jnci/90.22.1735. J Natl Cancer Inst. 1998. PMID: 9827529
-
A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.Cancer Res. 1996 Sep 15;56(18):4124-9. Cancer Res. 1996. PMID: 8797578
-
Regulation of organic anion transport in the liver.Yale J Biol Med. 1997 Jul-Aug;70(4):435-45. Yale J Biol Med. 1997. PMID: 9626764 Free PMC article. Review.
-
[Hepatic metabolism and transport of bilirubin and other organic anions].Nihon Rinsho. 1996 Aug;54(8):2276-90. Nihon Rinsho. 1996. PMID: 8810807 Review. Japanese.
Cited by
-
MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver.Br J Cancer. 1999 Jul;80(9):1342-9. doi: 10.1038/sj.bjc.6690527. Br J Cancer. 1999. PMID: 10424734 Free PMC article.
-
Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues.Biochem J. 2002 Feb 1;361(Pt 3):497-503. doi: 10.1042/0264-6021:3610497. Biochem J. 2002. PMID: 11802779 Free PMC article.
-
Whole genome resequencing reveals an association of ABCC4 variants with preaxial polydactyly in pigs.BMC Genomics. 2020 Mar 30;21(1):268. doi: 10.1186/s12864-020-6690-1. BMC Genomics. 2020. PMID: 32228435 Free PMC article.
-
MRP3, an organic anion transporter able to transport anti-cancer drugs.Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6914-9. doi: 10.1073/pnas.96.12.6914. Proc Natl Acad Sci U S A. 1999. PMID: 10359813 Free PMC article.
-
Recent Trends in Nanocarrier-Based Drug Delivery System for Prostate Cancer.AAPS PharmSciTech. 2024 Mar 6;25(3):55. doi: 10.1208/s12249-024-02765-2. AAPS PharmSciTech. 2024. PMID: 38448649 Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases